BioXcel Therapeutics Inc
NASDAQ:BTAI
BioXcel Therapeutics Inc
Cash from Investing Activities
BioXcel Therapeutics Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioXcel Therapeutics Inc
NASDAQ:BTAI
|
Cash from Investing Activities
-$20k
|
CAGR 3-Years
60%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-24%
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is BioXcel Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-20k
USD
Based on the financial report for Dec 31, 2023, BioXcel Therapeutics Inc's Cash from Investing Activities amounts to -20k USD.
What is BioXcel Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
43%
Over the last year, the Cash from Investing Activities growth was 86%. The average annual Cash from Investing Activities growth rates for BioXcel Therapeutics Inc have been 60% over the past three years , 43% over the past five years .